Log In
BCIQ
Print this Print this
 

WCK 771

  Manage Alerts
Collapse Summary General Information
Company Wockhardt Ltd.
DescriptionIV tricyclic fluoroquinolone
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationStaphylococcus
Indication DetailsTreat methicillin-resistant Staphylococcus aureus (MSRA) infections
Regulatory Designation U.S. - Qualified Infectious Disease Program (Treat methicillin-resistant Staphylococcus aureus (MSRA) infections)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today